Skip to main content
TipRanks
Go Ultimate75% OFF

CARsgen Therapeutics Holdings Ltd. (2171) Income Statement

3 Followers

CARsgen Therapeutics Holdings Ltd. Income Statement

Last quarter (Q2 2026), CARsgen Therapeutics Holdings Ltd.'s total revenue was ¥61.92M, an increase of 876.64% from the same quarter last year. In Q2, CARsgen Therapeutics Holdings Ltd.'s net income was ¥-66.66M. See CARsgen Therapeutics Holdings Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 125.66M¥ 39.42M¥ 0.00¥ 0.00¥ 25.81M
¥ 79.95M¥ 14.75M¥ 0.00¥ 0.00¥ 25.81M
¥ 184.16M¥ 822.94M¥ 767.65M¥ 881.30M¥ 599.72M
Depreciation and Amortization¥ 29.50M¥ 79.56M¥ 87.39M¥ 81.53M¥ 52.45M
¥ -198.40M¥ -482.66M¥ -697.65M¥ -724.11M¥ -534.95M
¥ -104.21M¥ -808.19M¥ -767.65M¥ -881.30M¥ -573.90M
¥ 1.30M¥ 10.40M¥ 20.26M¥ -9.65M¥ -4.16B
¥ -102.91M¥ -797.79M¥ -747.39M¥ -890.95M¥ -4.74B
¥ -97.86M¥ -798.13M¥ -747.79M¥ -892.25M¥ -4.74B
Per Share Metrics
Basic EPS¥ -0.18¥ -1.44¥ -1.34¥ -1.62¥ -12.26
Diluted EPS¥ -0.18¥ -1.44¥ -1.34¥ -1.62¥ -12.26
Weighted Average Shares Outstanding552.06M552.88M556.13M551.63M549.89M
Weighted Average Shares Outstanding (Diluted)552.06M552.88M556.13M551.63M549.89M

Currency in CNY

CARsgen Therapeutics Holdings Ltd. Earnings and Revenue History

-5B-2.5B02.5B-24000 %-16000 %-8000 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin